Reassurance from second trimester sonographic placental scan for pregnancies complicated by abnormal first trimester biomarkers

References

• Huang T, Meschino WS, Teitelbaum M, et al. Enhanced first trimester screening for trisomy 21 with contingent cell-free fetal DNA: a comparative performance and cost analysis. J Obstet Gynaecol Can. 2017;39(9):742–749.
   PubMed Web of Science ®Google Scholar
• Allen RE, Rogozinska E, Cleverly K, et al. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;182:194–201.
   PubMed Web of Science ®Google Scholar
• Chau K, Hennessy A, Makris A. Placental growth factor and pre-eclampsia. J Hum Hypertens. 2017;31(12):782–786.
   PubMed Web of Science ®Google Scholar
• Poon LCY, Zaragoza E, Akolekar R, et al. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Prenat Diagn. 2008;28(12):1110–1115.
   PubMed Web of Science ®Google Scholar
• Lakhi N, Govind A, Moretti M, et al. Maternal serum analytes as markers of adverse obstetric outcome. Obstet Gynecol. 2012;14(4):267–273.
   Google Scholar
• Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol. 2011;204(4):288–300.
   PubMed Web of Science ®Google Scholar
• Barker DJP. Developmental origins of adult health and disease. J Epidemiol Community Health. 2004;58(2):114–115.
   PubMed Web of Science ®Google Scholar
• Gagnon A, Wilson RD, Audibert F, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Canada. 2008;30(10):918–932.
   PubMedGoogle Scholar
• Sokol Karadjole V, Agarwal U, Berberovic E, et al. Does serial 3rd trimester ultrasound improve detection of small for gestational age babies: comparison of screening policies in 2 European maternity units. Eur J Obstet Gynecol Reprod Biol. 2017;215:45–49.
   PubMed Web of Science ®Google Scholar
• McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018;218(2):S855–S68.
   PubMed Web of Science ®Google Scholar
• Vayssière C, Sentilhes L, Ego A, et al. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol. 2015;193:10–18.
   PubMed Web of Science ®Google Scholar
• NZMFMN. Guidelinew for the management of suspected small for gestational age singleton pregnancies and infants after 34 weeks’ gestation. 2014.
   Google Scholar
• RCOG. The Investigation and Management of the Small–for–Gestational–Age Fetus – Green–top Guideline No. 31. 2013.
   Google Scholar
• IOG, RCPI. Fetal growth restriction – recognition, diagnosis and Management. 2017.
   Google Scholar
• Berkley E, Chauhan SP, Abuhamad A. Doppler assessment of the fetus with intrauterine growth restriction. Am J Obstet Gynecol. 2012;206(4):300–308.
   PubMed Web of Science ®Google Scholar
• Fetal Growth Restriction: ACOG practice bulletin, number 227. Obstet Gynecol. 2021;137:e16–28.
   PubMed Web of Science ®Google Scholar
• Sovio U, White IR, Dacey A, et al. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the pregnancy outcome prediction (POP) study: a prospective cohort study. Lancet. 2015;386(10008):2089–2097.
   PubMed Web of Science ®Google Scholar
• Kingdom JC, Audette MC, Hobson SR, et al. A placenta clinic approach to the diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S803–S17.
   PubMedGoogle Scholar
• Khong SL, Kane SC, Brennecke SP, et al. First-Trimester uterine artery doppler analysis in the prediction of later pregnancy complications. Dis Markers. 2015;2015:679730–679710.
   PubMed Web of Science ®Google Scholar
• Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108(2):E35.
   PubMed Web of Science ®Google Scholar
• Hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Wortelboer E, Koster M, Cuckle H, et al. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG an Int J Obstet Gynaecol. 2010;117(11):1384–1389.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Zaragoza E, Poon LCY, et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(6):732–739.
   PubMed Web of Science ®Google Scholar
• Goetzinger KR, Singla A, Gerkowicz S, et al. Predicting the risk of pre-eclampsia between 11 and 13 weeks’ gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG. Prenat Diagn. 2010;30(12–13):1138–1142.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn. 2010;30(4):293–308.
   PubMed Web of Science ®Google Scholar
• Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER trial). Am J Obstet Gynecol. 2004;191(4):1446–1451.
   PubMed Web of Science ®Google Scholar
• Litwinska M, Wright D, Efeturk T, et al. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks’ gestation. Ultrasound Obstet Gynecol. 2017;50(3):367–372.
   PubMedGoogle Scholar
• Callec R, Lamy C, Perdriolle-Galet E, et al. Impact on obstetric outcome of third-trimester screening for small-for-gestational-age fetuses. Ultrasound Obstet Gynecol. 2015;46(2):216–220.
   PubMed Web of Science ®Google Scholar
• Henrichs J, Verfaille V, Jellema P, et al. Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial. BMJ. 2019;367:l5517.
   Google Scholar
• Bricker L, Neilson JP, Dowswell T. Routine ultrasound in late pregnancy (after 24 weeks’ gestation). In: Bricker L, editor. Cochrane database syst. Rev., Chichester, UK: John Wiley & Sons, Ltd; 2008.
   Google Scholar
• Monier I, Blondel B, Ego A, et al. Poor effectiveness of antenatal detection of fetal growth restriction and consequences for obstetric management and neonatal outcomes: a French national study. BJOG. 2015;122(4):518–527.
   PubMed Web of Science ®Google Scholar
• Birbeck GL. The benefits of screening must outweigh the risks and costs. West J Med. 2000;172(5):308–309.
   PubMedGoogle Scholar
• Iragorri N, Spackman E. Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis. Public Health Rev. 2018;39:17.
   PubMed Web of Science ®Google Scholar
• Smith GCS. Universal screening for foetal growth restriction. Best Pract Res Clin Obstet Gynaecol. 2018;49:16–28.
   PubMed Web of Science ®Google Scholar